Otsuka (OTSKF) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd., trading on OTC markets as OTSKF, is a global healthcare company headquartered in Tokyo, Japan. Established in 1964 as a research-driven pharmaceutical firm, Otsuka has since evolved into a diversified holding company overseeing operations in pharmaceuticals, nutraceuticals and consumer products. The company operates through a network of subsidiaries, including Otsuka Pharmaceutical Co., Ltd., Otsuka America Pharmaceutical, Inc., and Otsuka Europe, each focusing on drug development, manufacturing and distribution.

In its pharmaceutical division, Otsuka is best known for discovering and commercializing treatments in areas such as psychiatry, oncology and nephrology. Flagship products include aripiprazole (marketed jointly with global partners for psychiatric disorders) and tolvaptan, a therapy for hyponatremia and polycystic kidney disease. The nutraceutical segment leverages Otsuka’s research capabilities to develop functional foods and beverages, with brands such as SoyJoy nutrition bars and Pocari Sweat, an electrolyte beverage popular in Asia.

Otsuka maintains a strong global presence, conducting research, clinical trials and manufacturing across Asia, North America, Europe and emerging markets. The company’s international network includes research centers in Japan and the United States, as well as regional marketing and distribution offices in Europe, China, India and Latin America. This broad footprint supports Otsuka’s commitment to meeting diverse healthcare needs and bringing innovative therapies to patients worldwide.

Research and development remain central to Otsuka’s strategy, with investments in novel drug delivery systems, digital therapeutics and next-generation small molecules. Collaborations with academic institutions, biotechnology firms and public health organizations further bolster the company’s pipeline. Guided by a board of directors based in Tokyo, Otsuka continues to pursue sustainable growth through scientific innovation, strategic partnerships and a focus on patient-centric solutions.

Key Stats

• Today's Range: $64.57 to $64.57
• 50-Day Range: $64.57 to $72.22
• 52-Week Range: $44.40 to $72.22
• Volume: 11 shs
• Average Volume: 221 shs
• Market Capitalization: N/A
• P/E Ratio: 0.21
• Dividend Yield: 86.38%
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 5/16/2026
• Next Earnings (Estimated): 7/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OTSKF
• CIK: 1544613
• Web: www.otsuka.com
• Phone: (136) 717-1410
• Fax: N/A
• Employees: 34,388
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.21
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A